Back to top

RTI Surgical's (RTIX) TETRAfuse Wins Spine Technology Award

Read MoreHide Full Article

RTI Surgical, Inc. (RTIX - Free Report) announced that its TETRAfuse 3D Technology has won the 2018 Spine Technology Award from Orthopedics This Week, a publication in the orthopedics industry.

The company is will accept the award at the North American Spine Society’s (NASS) 33rd Annual Meeting in Los Angeles.

What is TETRAfuse 3D Technology?

TETRAfuse 3D Technology is a spine-focused solution that meets the demands of surgeons and improves patient outcomes.

It is an interbody fusion (“IBF”) device material.

TETRAfuse 3D Technology is the first 3D printed polymer-based IBF device material that incorporates a nano-rough surface.

Other Developments in TETRAfuse

During the second quarter, RTI Surgical launched Fortilink-C IBF System, adding to a growing series of IBF devices that feature its proprietary TETRAfuse 3D technology.

The unique features of the 3D printed nano-rough surface have improved the anterior cervical discectomy and fusion (ACDF) surgeries.

Based on the positive feedback from users, management is confident about making “a new frontier in spine surgery”.

Per Markets And Markets, the global spinal implants market is estimated to reach $17.27 billion by 2021, at a CAGR of 5.3%. The growth can be attributed to an increase in procedure volumes, advancements in spine surgery devices, rising demand for minimally invasive spine surgery and technology adoption by new surgeons.

Consider these factors, we expect RTI Surgical to witness strong growth in the niche markets.

Spine Surgery in Focus

In January, the company acquired Zyga Technology Inc., a privately-held medical device company, based in Minnesota. By the end of the second quarter, management confirmed that the Zyga team has been witnessing impressive momentum in procedural and revenue performance.

RTI Surgical expects the Zyga Technology’s SImmetry Sacroiliac Joint Fusion System to leverage the competency of Spine franchise. The acquisition has been in sync with the company’s motto of strategic transformation toward increased operational excellence.

Price Performance & Zacks Rank

RTI Surgical has underperformed the industry on a year-to-date basis. The company has returned 12.2% compared with the industry’s rally of 27.1%.

However, the current level is higher than the S&P 500’s rise of 9.2%. The stock has a Zacks Rank #2 (Buy).

Other Key Picks

Other top-ranked stocks in the broader medical space are athenahealth (ATHN - Free Report) , Masimo Corporation (MASI - Free Report) and Veeva Systems (VEEV - Free Report) .

athenahealth has a long-term expected earnings growth rate of 17.6%. The stock sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Masimo’s long-term earnings growth rate is projected at 14.8%. The stock carries a Zacks Rank #2.

Veeva Systems’ long-term earnings growth rate is estimated at 19.3%. The stock carries a Zacks Rank #1.

The Hottest Tech Mega-Trend of All

Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.

See Zacks' 3 Best Stocks to Play This Trend >>



More from Zacks Analyst Blog

You May Like